<DOC>
	<DOCNO>NCT01258023</DOCNO>
	<brief_summary>The trial investigate efficacy adjuvanted seasonal influenza include H1N1 Fluad ( R ) immunocompromised adult undergone solid organ bone marrow transplantation . It expect administered vaccine fulfills serological efficacy criterion require elderly population age 60 year old .</brief_summary>
	<brief_title>Seasonal Flu Vaccine Adult Transplant Recipients</brief_title>
	<detailed_description />
	<criteria>Transplant Recipients : Adult subject 1860 year age undergone prior renal , cardiac , liver , lung , bone marrow transplantation reason , 3 month prior enrolment Patients able visit outpatient clinic life expectancy least one year Patients receive immunosuppressive treatment currently take prevent organ rejection Healthy Adults : Adult subject 1860 year age Healthy individual determine medical history , physical assessment clinical judgment investigator Within age category ( +/ 5 year ) incidental transplant patient Transplant Recipients Healthy Adults : Individuals able comply study procedure available clinic visit schedule study Women childbearing potential ( WOCBP ) must use acceptable contraceptive method least 2 month prior study entry 3 week vaccination : Female childbearing potential define post onset menarche premenopausal female capable become pregnant . This include females meet following condition : ( 1 ) menopause least 2 year earlier , ( 2 ) tubal ligation least 1 year earlier , ( 3 ) total hysterectomy Acceptable birth control method define one following : Hormonal contraceptive ( oral , injection , transdermal patch , implant , cervical ring , Barrier ( condom spermicide diaphragm spermicide ) every time intercourse , Intrauterine device ( IUD , Monogamous relationship vasectomize partner . Partner must vasectomize least six month prior subject 's study entry Individuals receive vaccine within 30 day prior study entry Individuals receive H1N1 seasonal influenza vaccination le 6 month prior study Influenza diagnose physician within 4 month prior study start Pregnant lactating female History anaphylactic ( i.e . lifethreatening ) reaction component vaccine , include egg chicken protein , ovalbumin , kanamycin neomycin sulphate , formaldehyde cetyltrimethylammonium bromide ( CTAB ) Subjects able comprehend follow require study procedure whole period study History current illness , opinion investigator , might interfere result study pose additional risk subject due participation study Temperature ≥ 38 °C oral temperature ≥ 38.5 °C within 3 day intend study vaccination Administration parenteral immunoglobulin compound include HBIg , blood product , and/or plasma derivative within 6 month prior Visit 1 plan full length study HIV infection , previously determine report History progressive severe neurological disorder ( include GuillainBarré syndrome convulsion , exclude febrile convulsion ) Subjects participate another clinical trial / receive investigational drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2012</verification_date>
</DOC>